| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 06/09/2005 | WO2005051901A1 Anti-cancer agents |
| 06/09/2005 | WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 06/09/2005 | WO2005051373A1 Receptor function regulating agent |
| 06/09/2005 | US20050124816 Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles |
| 06/09/2005 | US20050124815 Difluoromethyl thiazolyl carboxanilides |
| 06/09/2005 | US20050124683 Viricides; immunomoderators |
| 06/09/2005 | US20050124673 Inhibitors of enzymes for treatment of Aids or making intermediates |
| 06/09/2005 | US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124617 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | US20050123799 Luminescent material and organic electroluminescent device |
| 06/09/2005 | US20050123477 Benzothiazole derivatives for in vivo imaging of amloid plaques |
| 06/09/2005 | CA2547430A1 Receptor function regulating agent |
| 06/09/2005 | CA2543858A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 06/08/2005 | EP1538138A1 Substituted benzanilide compound and pest control agent |
| 06/08/2005 | EP1537091A1 Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
| 06/08/2005 | EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1537072A1 Substituted aminoethers for the treatment of alzheimer s disease |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1392673B1 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
| 06/08/2005 | EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 06/08/2005 | EP1309574B1 Method for purifying 2-chloro-5-chloromethyl thiazole |
| 06/08/2005 | EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 06/08/2005 | EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use |
| 06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1623537A Biaryl sulfonamides and its using method |
| 06/08/2005 | CN1205202C N-carbanilides used as pesticides |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903220 Synthesis of chiral 2-alkyl amino acids |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903133 Anticancer compounds |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903119 (2R)-N-(1-benzylpiperidin-4-yl)-3-cyclohexylmethylthio-2-((4R) -3-(pyridin-3-ylcarbonyl)thiazolidin-4-ylcarbonylamino)propana mide, calcium channel blocker, treatment of cerebral infarct, transient ischemic attack, spinal angiopathy |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049592A1 A novel process for ezetimibe intermediate |
| 06/02/2005 | WO2005049591A1 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | WO2005049557A1 Process for producing optically active 2-alkylcysteine, derivative thereof, and processes for production |
| 06/02/2005 | WO2005049018A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
| 06/02/2005 | WO2005048953A2 Amide derivatives as kinase modulators |
| 06/02/2005 | WO2005048948A2 Urea derivatives as kinase modulators |
| 06/02/2005 | US20050119467 Azo dye |
| 06/02/2005 | US20050119461 Which have affinity for oxazoline compounds; for treatment of glaucoma, dementia, mood disturbances, degenerative conditions, and neurodegenerative diseases |
| 06/02/2005 | US20050119453 Method of removing transition metals |
| 06/02/2005 | US20050119321 2-substituted-1,3-thiazole compounds |
| 06/02/2005 | US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 06/02/2005 | US20050119315 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators; potassium channel moderators; prevention fibrillation |
| 06/02/2005 | US20050119311 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119256 Aromatic amino acid derivates and medicinal compositions |
| 06/02/2005 | US20050119245 Alpha -, beta -, and gamma -amino acid derivatives, e.g., S)-2-{N'-[4-(4-Fluoro-phenoxy)-phenyl]-N''-cyano-guanidino}-3-phenyl-N-(3-pyrrolidin-1-yl-propyl)-propionamide for the treatment of central nervous system conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | DE10351088A1 Verfahren zum Herstellen von fluormethyl-substituierten Heterocyclen A method of producing fluoromethyl-substituted heterocycles |
| 06/02/2005 | CA2546324A1 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| 06/02/2005 | CA2545719A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
| 06/02/2005 | CA2545711A1 Urea derivatives as kinase modulators |
| 06/01/2005 | EP1535968A2 Process for the preparation of cyanine dyes with polysulfonate anions |
| 06/01/2005 | EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 06/01/2005 | EP1535906A1 Nitrogen-containing compounds |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534334A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/01/2005 | EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1207157B1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/01/2005 | EP1178977B1 Ion channel modulating agents |
| 06/01/2005 | EP1009758B1 Meta-benzamidine derivatives as serine protease inhibitors |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1622941A Glutaminyl based DPIV inhibitors |
| 06/01/2005 | CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2005 | CN1204129C Method for purifying 2-chloro-5-chloromethyl thiazole |
| 05/31/2005 | US6900331 Derivatives of epothilone B and D and synthesis thereof |
| 05/31/2005 | US6900237 Sulfonamide compounds as protease inhibitors |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/31/2005 | US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 05/31/2005 | US6899739 Hair dyes |
| 05/26/2005 | WO2005047273A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005046599A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 05/26/2005 | WO2005000843A3 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 05/26/2005 | US20050113546 Process for the preparation of cyanine dyes with polysulfonate anions |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113430 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazolines, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline; treating pruritus or pain, particularly that caused by a rheumatic disease |
| 05/26/2005 | US20050113422 5-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2,3-dihydro-indol-1-yl}-acetic acid methyl ester or an oxazole analogous compound; side effect reduction; non-insulin dependent diabetes; hypoglycemic agents; obesity; hyperlipemia; anticholesterol agents; atherosclerosis |
| 05/26/2005 | US20050113420 Methionine aminopeptidase inhibitor |
| 05/26/2005 | US20050113417 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |